Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial
Amy Burd(Leukemia and Lymphoma Society), John C. Byrd(University of Cincinnati), Elie Traer(Memorial Sloan Kettering Cancer Center), Wendy Stock(University of Chicago), Michael Boyiadzis(UPMC Hillman Cancer Center), Michael W. Deininger(Versiti Blood Center of Wisconsin), Uma Borate(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Vu H. Duong(University of Maryland, Baltimore), Martha Arellano(Memorial Sloan Kettering Cancer Center), Molly Miller(The Ohio State University), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Eric A. Severson(Brigham and Women's Hospital), Sonja Marcus(Leukemia and Lymphoma Society), Timothy J. Brennan(University of Iowa Hospitals and Clinics), Matthew C. Foster(University of North Carolina at Chapel Hill), Brian Druker(Oregon Health & Science University), Mona Stefanos(The Ohio State University), James M. Foran(Memorial Sloan Kettering Cancer Center), Tara L. Lin(Dana-Farber Cancer Institute), Gary J. Schiller(Fred Hutch Cancer Center), Maria R. Baer(University of Maryland, Baltimore), Olatoyosi Odenike(University of Chicago), Ashley O. Yocum(Leukemia and Lymphoma Society), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Prapti A. Patel(The University of Texas Southwestern Medical Center), Rebecca L. Olin(University of California, San Francisco), Leonard Rosenberg(Leukemia and Lymphoma Society), Abigail B. Shoben(The Ohio State University), Mark R. Litzow(Mayo Clinic in Arizona), Alison Walker(East Midlands Ambulance Service NHS Trust), Christine Vietz(Boston Foundation), Robert H. Collins(Texas Oncology), Timothy F. Chen(The University of Sydney), Brian Ball(Memorial Sloan Kettering Cancer Center), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Jo-Anne Vergilio(Harvard University Press), Nyla A. Heerema(The Ohio State University), Tibor Kovacsovics(Hôpital Edouard Herriot), William Blum(The Ohio State University)
Cited by 195
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k